Table 4

Age-specific prevalence of metabolic syndrome (MS) and its determinants by the IDF and NCEP ATPIII criteria
MS and Determinants Prevalence of determinants of metabolic syndrome by age and sex (%)a
IDF NCEP ATP III
All Male Female All Male Female
MS
35-44 34.0 12.8 46.3 14.2 2.6 20.9
45-64 36.7 16.1 72.2 16.3 8.1 30.6
P value b 0.679 0.649 0.012 0.665 0.255 0.276
Central Obesity
35-44 61.3 17.9 86.6 35.8 2.6 55.2
45-64 48.0 24.2 88.9 25.5 4.8 61.1
P value b 0.055 0.459 0.735 0.110 0.568 0.565
High BP
35-44 25.6 25.0 25.9 25.6 25.0 25.9
45-64 55.0 46.9 67.7 55.0 46.9 67.7
P value b <0.001 0.047 <0.001 <0.001 0.047 <0.001
High FPG
35-44 12.3 12.8 11.9 7.5 12.8 4.5
45-64 12.2 11.3 13.9 3.1 1.6 5.6
P value b 0.997 0.817 0.776 0.156 0.020 0.808
Low HDL
35-44 45.5 38.9 49.2 45.5 38.9 49.2
45-64 39.3 28.6 57.6 39.3 28.6 57.6
P value b 0.387 0.303 0.435 0.387 0.303 0.435
High TG
35-44 5.9 0.0 9.2 5.9 0.0 9.2
45-64 15.7 16.1 15.2 15.7 16.1 15.2
P value b 0.028 0.011 0.380 0.028 0.011 0.380

a Percentage of subjects in that age group out of studied subjects in the same age group.

b p-values (2-tailed) apply to the prevalence of the determinants of the metabolic syndrome across age groups.

Gyakobo et al.

Gyakobo et al. BMC Endocrine Disorders 2012 12:25   doi:10.1186/1472-6823-12-25

Open Data